Why would Platinum have any interest in taking over a biotech? Thats generally not what fund managers do, unless thats their investment mandate and they have balance sheets like Berkshire Hathaway (BS, not FUM!). Platinum have operated in this space for a long while and I can't recall that being a prior strategy. The risks are manifest and multiple and Platinum are fundamentally not operators of assets in this class.
Can you expand on the basis for your idea they might lob in a low-ball offer?
- Forums
- ASX - By Stock
- SNT
- Ann: SNT to Trial New Cancer Indication Following MRFF Grant
SNT
syntara limited
Add to My Watchlist
5.26%
!
6.0¢

Ann: SNT to Trial New Cancer Indication Following MRFF Grant, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.0¢ |
Change
0.003(5.26%) |
Mkt cap ! $97.55M |
Open | High | Low | Value | Volume |
5.6¢ | 6.0¢ | 5.5¢ | $129.4K | 2.258M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 209770 | 5.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.0¢ | 30132 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 209770 | 0.057 |
5 | 490351 | 0.056 |
4 | 1947310 | 0.055 |
1 | 60000 | 0.053 |
1 | 10219 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.060 | 30132 | 1 |
0.062 | 300000 | 1 |
0.067 | 343766 | 4 |
0.068 | 750000 | 1 |
0.069 | 100000 | 1 |
Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |